http://biz.yahoo.com/ic/news/511.htmlThe latest news on the Drug Manufacturers - Other industry from Yahoo! Financeen-usTue, 22 Dec 2009 02:59:33 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091221/us_teva_oncogenex_contract.html?.v=3Teva Pharmaceutical Industries Ltd. said Monday it will pay $60 million to OncoGenex Pharmaceuticals Inc. under terms of a new global licensing and partnership agreement covering OncoGenex's potential cancer treatment OGX-011.yahoo_finance/1656684937Tue, 22 Dec 2009 02:59:33 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091221/us_cephalon_nuvigil.html?.v=1The Food and Drug Administration needs more time to review Cephalon Inc.'s drug Nuvigil as a treatment for jet lag, Cephalon said Monday.yahoo_finance/1266665010Mon, 21 Dec 2009 23:19:25 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12k7dnjq2/*http%3A//philadelphia.bizjournals.com/philadelphia/stories/2009/12/21/daily10.html?ana=yfcpcyahoo_finance/1806338842Mon, 21 Dec 2009 23:05:20 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091221/to779.html?.v=3yahoo_finance/3858744580Mon, 21 Dec 2009 22:05:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091221/ph29415.html?.v=1Cephalon, Inc. today announced that the U.S. Food and Drug Administration has extended the action date to March 29, 2010, for its review of the supplemental New Drug Application for NUVIGIL® Tablets [C-IV].yahoo_finance/2798408583Mon, 21 Dec 2009 21:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12fo29j36/*http%3A//washington.bizjournals.com/washington/stories/2009/12/21/daily7.html?ana=yfcpcyahoo_finance/3658367830Mon, 21 Dec 2009 18:05:19 Etc/GMThttp://us.rd.yahoo.com/finance/external/xbarronsblog/rss/SIG=13n7qra1e/*http%3A//blogs.barrons.com/stockstowatchtoday/2009/12/21/new-wrinkle-in-health-care-bill-botox-ok-tanning-salons-not/?mod=yahoobarronsyahoo_finance/2292678131Mon, 21 Dec 2009 16:09:27 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=137p3hkk2/*http%3A//www.thestreet.com/_yahoo/story/10650359/1/oncogenex-slammed-on-teva-partnership-biobuzz.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/613028045Mon, 21 Dec 2009 15:47:24 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091221/la29059.html?.v=1Isis Pharmaceuticals, Inc. today announced that it will receive a $10 million payment from OncoGenex Pharmaceuticals, Inc.   as a result of OncoGenex' license of OGX-011 to Teva Pharmaceutical Industries Ltd. .  OGX-011 is a second-generation antisense drug co-discovered by Isis and OncoGenex that has completed a successful Phase 2 program in patients with advanced prostate cancer and advanced non-small cell lung cancer.  Teva and OncoGenex will collaborate on a global Phase 3 clinical program for OGX-011 in patients with prostate and non-small cell lung cancer.yahoo_finance/506049152Mon, 21 Dec 2009 13:15:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091221/20091221005249.html?.v=1JERUSALEM & BOTHELL, Wash. & VANCOUVER, British Columbia----Teva Pharmaceutical Industries Ltd. and OncoGenex Pharmaceuticals, Inc. announced today that they have entered into a global license and collaboration agreement to develop and commercialize OGX-011, as well as an agreement to purchase shares in OncoGenex.yahoo_finance/257919191Mon, 21 Dec 2009 13:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091221/cg28819.html?.v=1Dr. Carl W. Hastings, vice chairman and chief scientific officer of Reliv International, Inc., was elected to the board of directors of the Council for Responsible Nutrition , the nation's leading trade association for the dietary supplement industry.yahoo_finance/158017346Mon, 21 Dec 2009 13:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091218/28481.html?.v=1yahoo_finance/2330951694Fri, 18 Dec 2009 16:02:32 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091218/4045550en_uspublic.html?.v=1Teva UK Limited has launched generic co-beneldopa capsules in a variety of strengths. The company says that they are the first generic to reach the market.yahoo_finance/824098752Fri, 18 Dec 2009 15:56:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmpe/rss/SIG=12bq0d2dp/*http%3A//www.thestreet.com/p/_yahoo/rmoney/marketcommentary/10649052.html?cm_ven=YAHOO&cm_cat=PREMIUM&cm_ite=003190yahoo_finance/105777387Fri, 18 Dec 2009 15:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091218/20091218005105.html?.v=1EAST WINDSOR, N.J.----NexMed, Inc. , a specialty CRO and a developer of products based on the NexACT® technology, today announced that it received a letter from the NASDAQ Listing Qualifications Panel on December 17, 2009, informing the Company that the Panel had granted the Company’s request to remain listed on the NASDAQ Stock Market, subject to the condition that, on or before March 31, 2010, the Company evidence stockholders’ equity of at least $2.5 million or a market value of listed securities of at least $35 million, which are the applicable minimum requirements for the continued listing of the Company’s securities on The NASDAQ Capital Market.yahoo_finance/4209430924Fri, 18 Dec 2009 14:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=133obupa1/*http%3A//www.thestreet.com/_yahoo/story/10649119/1/smart-modular-cardiome-early-volume-plays.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/3624232800Fri, 18 Dec 2009 12:14:16 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091217/to725.html?.v=15yahoo_finance/2703103599Thu, 17 Dec 2009 23:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091217/us_amag_pharmaceuticals_personnel.html?.v=2Biotechnology company AMAG Pharmaceuticals Inc. said Thursday that director Mark Skaletsky is resigning and the company has appointed Dr. Lesley Russell to replace him on its board of directors.yahoo_finance/408075567Thu, 17 Dec 2009 22:13:47 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091217/us_medicines_company_recall.html?.v=3Federal health regulators are warning doctors about 11 recalled lots of an intravenous hypertension drug made by the Medicines Co. that are contaminated with bits of steel.yahoo_finance/631193643Thu, 17 Dec 2009 22:09:17 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091217/us_forest_laboratories_almirall.html?.v=2Forest Laboratories Holdings Ltd. said Wednesday it will pay Spanish drug developer Almirall SA $75 million upfront to collaborate on a potential asthma treatment using an experimental Almirall drug.yahoo_finance/3788800965Thu, 17 Dec 2009 22:05:26 Etc/GMT